MULTIFOCAL MOTOR NEUROPATHY (MMN)

Clinical trials for MULTIFOCAL MOTOR NEUROPATHY (MMN) explained in plain language.

Never miss a new study

Get alerted when new MULTIFOCAL MOTOR NEUROPATHY (MMN) trials appear

Sign up with your email to follow new studies for MULTIFOCAL MOTOR NEUROPATHY (MMN), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 2 Completed 1

New drug challenges standard therapy for debilitating nerve disease

Disease control Recruiting now

This study is testing whether a new drug called empasiprubart works as well as or better than the current standard treatment (IVIg) for adults with multifocal motor neuropathy (MMN), a rare condition that causes muscle weakness. About 115 participants will be randomly assigned to…

Matched conditions: MULTIFOCAL MOTOR NEUROPATHY (MMN)

Phase: PHASE3 • Sponsor: argenx • Aim: Disease control

Last updated Apr 02, 2026 03:41 UTC

MULTIFOCAL MOTOR NEUROPATHY (MMN)

Get alerted when new MULTIFOCAL MOTOR NEUROPATHY (MMN) trials appear

New drug challenges standard therapy for debilitating nerve disease